PCTC
DGX icon

Perkins Coie Trust Company’s Quest Diagnostics DGX Stock Holding History

Perkins Coie Trust Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,155
Closed -$207K – 306
2025
Q2 		$207K Hold
1,155
– – 0.04% 109
2025
Q1 		$195K Hold
1,155
– – 0.04% 109
2024
Q4 		$174K Hold
1,155
– – 0.04% 113
2024
Q3 		$179K Hold
1,155
– – 0.04% 117
2024
Q2 		$158K Hold
1,155
– – 0.04% 121
2024
Q1 		$154K Hold
1,155
– – 0.04% 111
2023
Q4 		$159K Sell
1,155
-5
-0.4% -$657 0.04% 111
2023
Q3 		$141K Buy
+1,160
New +$155K 0.04% 115
2020
Q2 		– Sell
-5
Closed – – 324
2020
Q1 		$0 Buy
+5
New +$518 ﹤0.01% 360

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Perkins Coie Trust Company's DGX Position: Q3 2025 in Review

Perkins Coie Trust Company sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 1,155 shares — an estimated $207K sold.

Perkins Coie Trust Company first reported a position in DGX in Q1 2020 and held it in 9 quarters. The position peaked at $207K in Q2 2025. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Perkins Coie Trust Company reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 1,155 Quest Diagnostics shares in Q3 2025, an estimated $207K.
  • Perkins Coie Trust Company first reported a position in Quest Diagnostics in Q1 2020 and held it in 9 quarters.
  • Perkins Coie Trust Company's Quest Diagnostics position peaked at $207K in Q2 2025.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Perkins Coie Trust Company's 13F filing for Q3 2025, filed 9 Oct 2025.